Win tickets to the ATP finals

Analysis of all the best trials on the subject has found little evidence that eating fish, or taking fish oil capsules, cuts the risk of dying of heart disease, stroke or cancer.
The finding may come as a shock to those who believe that the benefits of omega 3 fatty acids, which are found not just in fish oils but also, in short chain form, in some plant oils such as linseed oil.
The analysis indicates that, despite a lot of work and a multiplicity of trials, it is difficult to show clear benefits. The better the quality of the trial, the lower the apparent benefit.
The findings, published in the British Medical Journal online by a team led by Lee Hooper, of the University of East Anglia, are unlikely to go uncontested.
Other analyses, including one published as recently as 2002, have shown benefits.
Dr Hooper’s team, which included Professor George Davey-Smith, of Bristol University, searched the medical literature for studies of fish oil. They found 48 randomised control trials and 41 “cohort” studies.
Randomised control trials (RCTs) compare the effects of fish oil capsules with a placebo, while cohort studies compare groups with high intakes of fish oil against those with low intakes. RCTs are considered the best source of evidence available in medicine, while cohort studies rank lower.
The team pooled all the data from the studies to increase statistical power. When this was done there was no strong evidence of a reduced risk of dying among those taking supplements.
When only the better studies, with a lower risk of bias, were chosen, the evidence of benefit became even weaker.
These studies were more consistent but showed no evidence of benefit. Overall, they suggested that a 2 per cent reduction in risk, but the error margin was wide.
The benefit could have been as great as 30 per cent, or the disbenefit as much as 36 per cent. So fish oil could reduce deaths, or increase them. The only conclusion possible is that it has no significant effect.
Why does the finding differ from earlier studies? The authors suggest some possibilities. In the cohort studies, which have in the past suggested there is a benefit, it is impossible to eliminate bias.
People who take fish oil capsules differ in so many ways from those who do not that it is impossible to correct completely for these differences. Or, as the team says: “The web of lifestyle, interest in health and social factors seen in the cohort studies included in our review provides an advantage to people taking most omega 3 fats and this makes adequate adjustment for confounding difficult, if not impossible.”
So reliance has to be placed on RCTs, where the bias is smaller. Here they acknowledge that one recent study, by Michal Burr, of the University of Cardiff, had a significant influence on the final result.
Dr Burr found no benefit of fish oil, in a study that included 525 deaths, the second largest conducted, and with the longest follow-up.
Attempting to explain why Dr Burr should have reached the conclusions he did, the team suggest that fish oil may have a short-term benefit, but a long-term disbenefit, because it contains traces of toxic methyl mercury as a contaminant. Another possibility is that the beneficial effects may be limited to small groups of people — such as those with heart failure or those who have had a heart attack — who were not included in the Burr study.
At present, the team says, British dietary guidelines recommend that people eat more oily fish, especially if they have had a heart attack. This advice should not change, they say, but should be regularly reviewed.
They add that it is probably not appropriate to recommend fish oil to people who have angina but who have not had a heart attack.
Trials show that people given the plant-produced version of omega 3 experienced no greater improvement in health than those taking fish oil.
Industry sectors news at a glance. Interactive heatmap, video and podcast
Everything the Business Traveller needs to know to make a better trip
Get ready for the winter sports season, with our resort guides and snow reports
We are backing British business, what is the confidence of the nation and what businesses are succeeding?
Growing demand for energy, oil that is harder to reach and the rise of carbon dioxide emissions. We examine the energy challenge
Enjoy further reading from Travel to Fashion, Business to Sport, discover more
Shortcuts to help you find sections and articles
36-month car lease
on contract hire for
£359.99 plus VAT pm
12 months for the price of 11 and a 5% discount.
Offer ends 31/11/09
The UK's leading alternative to showroom finance.
Finance packages tailored to your needs.
Minimum loan of £15,000
Car Insurance
£12,578 per annum
The Independent Housing Ombudsman
London
Competitive
Barclaycard
Not Specified
The Sheppard Trust
London
£80-95,000
Clay McGuire Executive Selection
Moments from Battersea Park.
For sale with Winkworth.
See your free Experian credit report beforehand
Book now & save over £100pp.
11 cool resorts, lowest prices... Early Booking offers 15 Nov.
20% off selected Azores holidays taken in October with Sunvil Discovery
Get covered on your travels with a superb range of policies at great prices. Visit InsureandGo.com
World Class Golf, Spa and preferential Beach Club. Private estate overlooking West Coast
Villas from £275 per night inclusive of Golf
Contact our advertising team for advertising and sponsorship in Times Online, The Times and The Sunday Times, or place your advertisement.
Times Online Services: Dating | Jobs | Property Search | Used Cars | Holidays | Births, Marriages, Deaths | Subscriptions | E-paper
News International associated websites: Globrix Property Search | Milkround
Copyright 2009 Times Newspapers Ltd.
This service is provided on Times Newspapers' standard Terms and Conditions. Please read our Privacy Policy.To inquire about a licence to reproduce material from Times Online, The Times or The Sunday Times, click here.This website is published by a member of the News International Group. News International Limited, 1 Virginia St, London E98 1XY, is the holding company for the News International group and is registered in England No 81701. VAT number GB 243 8054 69.